Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
NCT00318162
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Pervasive Developmental Disorder
Interventions
DRUG:
low dose naltrexone
Sponsor
Hadassah Medical Organization
Collaborators
[object Object]